“Ghost Peak” Driven Structural Elucidation of a Photocatalytic Degradation Product from Brexpiprazole

18 April 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Brexpiprazole which marketed as Rexulti® is a second-generation atypical antipsychotic. A seemingly random and uncontrollable “ghost peak” that vary from below the detection limit to ∼0.2% was observed occasionally during the development of HPLC method for brexpiprazole drug substance. The “ghost peak” was finally characterized as a syn head-to-tail dimer of brexpiprazole by UV, IR, LC–MS/TOF, 1D and 2D NMR. It was formed rapidly through photocatalytic [2 + 2] pericyclic reaction and can reach approximately 1.7% in five minutes once the analytes were exposed to sunlight at noon. By contrast, the occurrence of this “ghost peak” in brexpiprazole can be suppressed when the solutions were prepared and stored away from sunlight.


Ghost peak
Photocatalytic [2+2] pericyclic reaction


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.